IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) has been given an average rating of "Moderate Buy" by the seven ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $46.50.
IPX has been the subject of several research analyst reports. Jefferies Financial Group initiated coverage on IperionX in a research report on Wednesday, September 2nd. They issued a "buy" rating and a $26.00 price objective for the company. Roth Capital set a $53.00 target price on IperionX in a report on Wednesday, August 5th. BTIG Research raised their target price on IperionX from $40.00 to $55.00 and gave the company a "buy" rating in a research note on Friday, June 5th. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of IperionX in a report on Friday, July 17th.
Get Our Latest Report on IperionX
IperionX Price Performance
NASDAQ IPX opened at $20.97 on Friday. IperionX has a one year low of $17.40 and a one year high of $61.45. The stock's 50 day simple moving average is $22.32 and its 200 day simple moving average is $29.66. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03.
Insider Transactions at IperionX
In related news, CEO Anastasios Arima bought 138,720 shares of the company's stock in a transaction on Friday, July 10th. The stock was bought at an average cost of $3.58 per share, with a total value of $496,617.60. Following the completion of the purchase, the chief executive officer owned 12,455,502 shares in the company, valued at approximately $44,590,697.16. The trade was a 1.13% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Todd Hannigan bought 300,000 shares of IperionX stock in a transaction dated Monday, July 13th. The shares were bought at an average price of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the transaction, the chairman directly owned 26,633,334 shares of the company's stock, valued at $95,613,669.06. This represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders have acquired 663,720 shares of company stock worth $2,379,118.
Institutional Trading of IperionX
Hedge funds and other institutional investors have recently modified their holdings of the stock. Private Advisor Group LLC raised its position in IperionX by 69.9% in the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock worth $1,643,000 after purchasing an additional 25,964 shares during the last quarter. Corigliano Investment Advisers LLC acquired a new stake in shares of IperionX in the 4th quarter valued at $362,000. XY Capital Ltd acquired a new stake in shares of IperionX in the 4th quarter valued at $290,000. DLD Asset Management LP bought a new stake in shares of IperionX during the first quarter worth $260,000. Finally, Connective Capital Management LLC bought a new stake in shares of IperionX during the second quarter worth $160,000. Institutional investors and hedge funds own 2.76% of the company's stock.
About IperionX
(
Get Free Report)
IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a low-carbon, fully integrated titanium supply chain in the United States. The company is working to produce titanium metal and titanium products from locally sourced mineral resources, with applications across the aerospace, defense, automotive, medical and consumer industries.
IperionX's flagship asset is the Titan Project in Tennessee, which contains titanium, rare earth and zircon-rich mineral sands.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IperionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.
While IperionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.